Initiating coverage on Trulieve Cannabis with a "Buy" rating, driven by potential regulatory catalysts and strong fundamentals, over a 24-month investment horizon.Florida's potential legalization of ...
Source LinkInitiating coverage on Trulieve Cannabis with a "Buy" rating, driven by potential regulatory catalysts and strong fundamentals, over a 24-month investment horizon.Florida's potential legalization of ...
Source Link
Comments